Supplementary Figure. Genomic Structure of nOPV2-c1 Vaccine Strain With Genetic Modifications Responsible for Attenuation, Increased Genetic Stability and Reduced Potential for Recombination Engineered in nOPV2 and Location of Key Mutations and Recombination Junctions§ Identified in nOPV2 Isolates

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

i

Supplementary Figure. Genomic Structure of nOPV2-c1 Vaccine Strain With Genetic Modifications Responsible for Attenuation, Increased Genetic Stability and Reduced Potential for Recombination Engineered in nOPV2 and Location of Key Mutations and Recombination Junctions§ Identified in nOPV2 Isolates

06/17/2022
By Centers for Disease Control and Prevention (U.S.)
Source: MMWR: Morbidity and Mortality Weekly Report 2022; v. 71, no. 24
Series: Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

English

Details You May Also Like

Details:

Alternative Title:

Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing — Worldwide, March–October 2021: Supplementary Figure. Genomic Structure of nOPV2-c1 Vaccine Strain With Genetic Modifications Responsible for Attenuation, Increased Genetic Stability and Reduced Potential for Recombination Engineered in nOPV2 and Location of Key Mutations and Recombination Junctions§ Identified in nOPV2 Isolates
Corporate Authors:

Centers for Disease Control and Prevention (U.S.)
Source:

MMWR: Morbidity and Mortality Weekly Report 2022; v. 71, no. 24
Series:

Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
ISSN:

0149-2195 (print);1545-861X (digital);
Pages in Document:

1 pdf page
Volume:

71
Issue:

24
Collection(s):

Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:

[+]

urn:sha-512:620320259eeb02e2e45d686b2100492ba1bc4c278136b627a9a53ed0f4a2ff4b1937943a38e5e82a463fc88d97e0eb9a3b4e4669338856f5da5b2e8c9e49cfa0
Download URL:

https://stacks.cdc.gov/view/cdc/118054/cdc_118054_DS1.pdf
File Type:

[PDF-228.87 KB]